Want to see GB:POLB full AI Analyst Report?
Poolbeg Pharma Ltd. (POLB) Income Statement
Poolbeg Pharma Ltd. Income Statement
Last quarter (Q2 2026), Poolbeg Pharma Ltd.'s total revenue was $0.00. In Q2, Poolbeg Pharma Ltd.'s net income was $-1.94M. See Poolbeg Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -59.00K | $ -114.00K | $ -26.00K | $ -26.00K | $ -18.00K | |
| $ 6.36M | $ 6.37M | $ 5.04M | $ 4.99M | $ 2.36M | |
| Depreciation and Amortization | $ 59.00K | $ 114.00K | $ 26.00K | $ 26.00K | $ 18.00K |
| $ -6.36M | $ -6.00M | $ -4.66M | $ -4.75M | $ -2.32M | |
| $ -6.42M | $ -6.62M | $ -5.04M | $ -4.99M | $ -2.38M | |
| $ 640.00K | $ 674.00K | $ 534.00K | $ 209.00K | $ 42.00K | |
| $ -5.77M | $ -5.94M | $ -4.50M | $ -4.78M | $ -2.34M | |
| $ -5.70M | $ -5.79M | $ -3.93M | $ -4.69M | $ -2.34M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.01 | $ -7.90 | $ -9.37 | $ -4.67 |
| Diluted EPS | $ -0.01 | $ -0.01 | $ -7.86 | $ -9.37 | $ -4.67 |
| Weighted Average Shares Outstanding | 602.65M | 499.14M | 497.59M | 500.00M | 500.00M |
| Weighted Average Shares Outstanding (Diluted) | 602.65M | 500.00M | 497.59M | 500.00M | 500.00M |
Currency in GBP